| abstract |
The present invention relates to compounds useful as inhibitors of protein kinases. The present invention further provides pharmaceutically acceptable compositions comprising these compounds and methods of treating various diseases, conditions and disorders using the compounds and compositions described above. The present invention further provides a process for preparing the compounds of the present invention. These compounds and their pharmaceutically acceptable compositions are useful for inhibiting kinases in vitro, in vivo and ex vivo. Such uses include the treatment or prevention of myeloproliferative disorders and proliferative disorders such as melanoma, myeloma, leukemia, lymphoma, neuroblastoma and cancer. |